The heme oxygenase-1 genotype is a risk factor to renal impairment of IgA nephropathy at diagnosis, which is a strong predictor of mortality

Journal of Korean Medical Science

Volumn 24, Issue SUPPL.1, 2009, Pages

  Chin, Ho Jun ^a,b   Cho, Hyun Jin ^a   Lee, Tae Woo ^b   Na, Ki Young ^a   Yoon, Hyung Jin ^c   Chae, Dong Wan ^a,b   Kim, Suhnggwon ^b   Jeon, Un Sil ^d   Do, Jun Young ^e   Park, Jong Won ^e   Yoon, Kyung Woo ^e   Shin, Young Tai ^f   Lee, Kang Wook ^f   Na, Ki Ryang ^f   Cha, Dae Ryong ^g,x   Kang, Young Sun ^g   Jang, Eun Hee ^h   Kim, Won ⁱ   Kim, Nam Ho ^j   Bae, Woo Kyun ^j   Kim, Hye Young ^k   Ahn, Ki Sung ^l   Cho, Jong Tae ^m   Lee, Eun Kyeong ^m   Kim, Ki Hyun ⁿ   An, WonSuk ⁿ   Kim, Seong Eun ⁿ   Bog, Choi Gyu ^o   Kim, Seung Jung ^o   Chung, Woo Kyung ^p   Lee, Hyun Hee ^p   Yang, Jaeseok ^p   Kim, Sejoong ^q   Chang, Se Ho ^r   Noh, Jung Woo ^s   Lee, Young Ki ^s   Kim, Seong Gyun ^s   Oh, Jieun ^s   Song, Young Rim ^s   Kim, Moon Jae ^t   Lee, Seoung Woo ^t   Kim, Yeong Hoon ^u   Park, Won Do ^u   Kim, Hyun Chul ^v   Park, Sung Bae ^v   Kim, Kyo Soon ^w   Cho, Won Yong ^g   Kim, Hyoung Kyu ^g   Jo, Sang Kyung ^g   Sun, Kang Young ^x   Kwon, Young Joo ^y   Kim, Yong Lim ^z   Park, Sun Hee ^z   Kim, Chan Duck ^z   Yang, Dong Ho ^aa   Kwak, Ihm Soo ^ab   Lee, Soo Bong ^ab   Lee, Dong Won ^ab   Song, Sang Heon ^ab   Seoung, Eun Young ^ab   Yoon, Su Jin ^b   Lim, Chun Soo ^ac   Oh, Yoon Kyu ^ac   Oh, Kook Hwan ^ad   Joo, Kwon Wook ^ad   Kim, Yon Su ^ad   Ahn, Curie ^ad   Han, Jin Suk ^ad   Lee, Kyu Beck ^ae   Kim, Yoon Goo ^ae   Lee, Jung Eun ^ae   Lee, Sang Koo ^af   more..

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Seoul National University Biomedical Research Institute   (South Korea)

^d Pohang University of Science and Technology (POSTECH)   (South Korea)

^e Yeungnam University College of Medicine   (South Korea)

^f Chungnam National University College of Medicine   (South Korea)

^g Korea University College of Medicine   (South Korea)

^h Jeju National University   (South Korea)

ⁱ Chonbuk National University Medical School   (South Korea)

^j Chonnam National University Medical School   (South Korea)

^k Chungbuk National University College of Medicine   (South Korea)

^l Catholic University of Daegu   (South Korea)

^m Dankook University   (South Korea)

ⁿ Dong A University College of Medicine   (South Korea)

^o Ewha Womans University School of Medicine   (South Korea)

^p Gachon University College of Medicine   (South Korea)

^q Gyeongsang National University   (South Korea)

^r Hallym University College of Medicine   (South Korea)

^s Inha University School of Medicine   (South Korea)

^t Inje University College of Medicine   (South Korea)

^u Keimyung University School of Medicine   (South Korea)

^v Konkuk University School of Medicine   (South Korea)

^w Korea University College of Medicine   (South Korea)

^x Korea University College of Medicine   (South Korea)

^y Kyungpook National University School of Medicine   (South Korea)

^z CHA University   (South Korea)

^aa Pusan National University School of Medicine   (South Korea)

^ab Seoul Medical Center   (South Korea)

^ac Seoul National University Hospital   (South Korea)

^ad Seoul National University   (South Korea)

^ae Sungkyunkwan University School of Medicine   (South Korea)

^af University of Ulsan College of Medicine   (South Korea)

more..

Author keywords

Glomerulonephritis; Heme oxygenase; IGA; Renal insufficiency

Indexed keywords

HEME OXYGENASE 1;

ADULT; ARTICLE; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROMOTER REGION; RISK; RISK FACTOR;

ADULT; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENOTYPE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; HEME OXYGENASE-1; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 62449084818     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2009.24.S1.S30     Document Type: Article

References (37)

1. Courtney AE, Maxwell AP. Heme oxygenase 1: does it have a role in renal cytoprotection? Am J Kid Dis 2008; 51: 678-90.
2. Nakagami T, Toyomura K, Kinoshita T, Morisawa S. A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. Biochim Biophys Acta 1993; 1158: 189-93.
3. Vachharajani TJ, Work J, Issekutz AC, Granger DN. Heme oxygenase modulates selectin expression in different regional vascular beds. Am J Physiol Heart Circ Physiol 2000; 278: H1613-7.
4. Otterbein LE, Zuckerbraun BS, Haga M, Liu F, Song R, Usheva A, Stachulak C, Bodyak N, Smith RN, Csizmadia E, Tyagi S, Akamatsu Y, Flavell RJ, Billiar TR, Tzeng E, Bach FH, Choi AM, Soares MP. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat Med 2003; 9: 183-90.
5. Gunther L, Berberat PO, Haga M, Brouard S, Smith RN, Soares MP, Bach FH, Tobiasch E. Carbon monoxide protects pancreatic beta-cells from apoptosis and improves islet function/survival after transplantation. Diabetes 2002; 51: 994-9.
6. Brouard S, Otterbein LE, Anrather J, Anrather J, Tobiasch E, Bach FH, Choi AM, Soares MP. Carbon monoxide generated by heme oxygenase I suppresses endothelial cell apoptosis. J Exp Med 2000; 192: 1015-26.
7. Kanakiriya SK, Croatt AJ, Haggard JJ, Ingelfinger JR, Tang SS, Alam J, Nath KA. Heme: a novel inducer of MCP-1 through HOdependent and HO-independent mechanisms. Am J Physiol Renal Physiol 2003; 284: F546-54.
8. Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, Choi AM. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med 2000; 6: 422-8.
9. Inguaggiato P, Gonzalez-Michaca L, Croatt AJ, Haggard JJ, Alam J, Nath KA. Cellular overexpression of heme oxygenase-I up-regulates p21 and confers resistance to apoptosis. Kidney Int 2001; 60: 2181-91.
10. Gonzalez-Michaca L, Farrugia G, Croatt AJ, Alam J, Nath KA. Heme: a determinant of life and death in renal tubular epithelial cells. Am J Physiol Renal Physiol 2004; 286: F370-7.
11. Woo J, Iyer S, Cornejo MC, Mori N, Gao L, Sipos I, Maines M, Buelow R. Stress protein induced immunosuppression: Inhibition of cellular immune effector functions following overexpression of haem oxygenase (HSP 32). Transpl Immunol 1998; 6: 84-93.
12. Nath KA, Balla G, Vercellotti GM, Balla J, Jacob HS, Levitt MD, Rosenberg ME. Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 1992; 90: 267-70.
13. Maines MD, Mayer RD, Ewing JF, McCoubrey WK Jr. Induction of kidney heme oxygenase-1 (HSP 32) mRNA and protein by ischemia/ reperfusion: possible role of heme as both promotor of tissue damage and regulator of HSP32. J Pharmacol Exp Ther 1993; 264: 457-62.
14. Shimizu H, Takahashi T, Suzuki T, Yamasaki A, Fujiwara T, Odaka Y, Hirakawa M, Fujita H, Akagi R. Protective effect of heme oxygenase induction in ischemic acute renal failure. Crit Care Med 2000; 28: 809-17.
15. Mosley K, Wembridge DE, Cattell V, Cook HT. Heme oxygenase is induced in nephrotoxic nephritis and hemin, a stimulator of heme oxygenase synthesis, ameliorates disease. Kidney Int 1998; 53: 672-8.
16. Datta PK, Koukouritaki SB, Hopp KA, Lianos EA. Heme oxygenase-induction attenuates inducible nitric oxide synthase expression and proteinuria in glomerulonephritis. J Am Soc Nephrol 1999; 10: 2540-50.
17. Exner M, Bohmig GA, Schillinger M, Regele H, Watschinger B, Horl WH, Raith M, Mannhalter C, Wagner OF. Donor heme oxygenase-genotype is associated with renal allograft function. Transplantation 2004; 77: 538-42.
18. Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, Koizumi S. Oxidative stress causes enhanced endothelial injury in human heme oxygenase-1 deficiency. J Clin Invest 1999; 103: 129-35.
19. Yamada N, Yamaya M, Okinaga S, Nakayama K, Sekizawa K, Shibahara S, Sasaki H. Microsatellite polymorphism in the heme oxygenase-gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 2000; 66: 187-95.
20. Chen YH, Lin SJ, Lin MW, Tsai HL, Kuo SS, Chen JW, Charng MJ, Wu TC, Chen LC, Ding YA, Pan WH, Jou YS, Chau LY. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients. Hum Genet 2002; 111: 1-8.
21. Hirai H, Kubo H, Yamaya M, Nakayama K, Numasaki M, Kobayashi S, Suzuki S, Shibahara S, Sasaki H. Microsatellite polymorphism in heme oxygenase-1 gene promoter is associated with susceptibility to oxidant-induced apoptosis in lymphoblastoid cell lines. Blood 2003; 102: 1619-21.
22. Kaneda H, Ohno M, Taguchi J, Togo M, Hashimoto H, Ogasawara K, Aizawa T, Ishizaka N, Nagai R. Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol 2002; 22: 1680-5.
23. Kikuchi A, Yamaya M, Suzuki S, Yasuda H, Kubo H, Nakayama K, Handa M, Sasaki T, Shibahara S, Sekizawa K, Sasaki H. Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism. Hum Genet 2005; 116: 354-60.
24. Baan C, Peeters A, Lemos F, Uitterlinden A, Doxiadis I, Claas F, Ijzermans J, Roodnat J, Weimar W. Fundamental role for HO-1 in the self-protection of renal allografts. Am J Transplant 2004; 4: 811-8.
25. Courtney AE, McNamee PT, Heggarty S, Middleton D, Maxwell AP. Association of functional haem oxygenase-1 gene promoter polymorphism with polycystic kidney disease and IgA nephropathy. Nephrol Dial Transplant 2008; 23: 608-11.
26. Barratt J, Feehally J. IgA nephropathy. J Am Soc Nephrol 2005; 16: 2088-97.
27. Descamps-Latscha B, Witko-Sarsat V, Nguyen-Khoa T, Nguyen AT, Gausson V, Mothu N, Cardoso C, Noel LH, Guerin AP, London GM, Jungers P. Early detection of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers. Kidney Int 2004; 66: 1606-12.
28. Chen HC, Tomino Y, Yaguchi Y, Fukui M, Yokoyama K, Watanabe A, Koide H. Oxidative metabolism of polymorphonuclear leukocytes (PMN) in patients with IgA nephropathy. J Clin Lab Anal 1992; 6: 35-9.
29. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-100.
30. Kaneda H, Ohno M, Taguchi J, Togo M, Hashimoto H, Ogasawara K, Aizawa T, Ishizaka N, Nagai R. Heme Oxygenase-1 Gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors. Arterioscler Thromb Vasc Biol 2002; 22: 1680-5.
31. Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH. Carbon monoxide: a putative neural messenger. Science 1993; 259: 381-4.
32. Funk M, Endler G, Schillinger M, Mustafa S, Hsieh K, Exner M, Lalouschek W, Mannhalter C, Wagner O. The effect of a promoter polymorphism in the heme oxygenase-1 gene on the risk of ischaemic cerebrovascular events. The influence of other vascular risk factors. Thromb Res 2004; 113: 217-23.
33. Wijpkema JS, van Haelst PL, Monraats PS, Bruinenberg M, Zwinderman AH, Zijlstra F, van der Steege G, de Winter RJ, Doevendans PA, Waltenberger J, Jukema JW, Tio RA. Restenosis after percutaneous coronary intervention is associated with the angiotensin-II type-1 receptor 1166A/C polymorphism but not with polymorphisms of angiotensin-converting enzyme, angiotensin-II receptor, angiotensinogen or heme oxygenase-1. Pharmacogenet Genomics 2006; 16: 331-7.
34. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
35. Toth B, Yokoyama Y, Kuebler JF, Schwacha MG, Rue LW 3rd, Bland KI, Chaudry IH. Sex differences in hepatic heme oxygenase expression and activity following trauma and hemorrhagic shock. Arch Surg 2003; 138: 1375-82.
36. Zampino M, Yuzhakova M, Hansen J, McKinney RD, Goldspink PH, Geenen DL, Buttrick PM. Sex-related dimorphic response of HIF-1 alpha expression in myocardial ischemia. Am J Physiol Heart Circ Physiol 2006; 291: H957-64.
37. Hong JS, Yi SW, Kang HC, Jee SH, Kang HG, Bayasgalan G, Ohrr H. Age at menopause and cause-specific mortality in South Korean Women: Kangwha Cohort Study. Maturitas 2007; 56: 411-9.